1OBL

crystal structure of the S133A mutant of Malonamidase E2 complexed with malonate from Bradyrhizobium japonicum


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2 Å
  • R-Value Free: 0.245 
  • R-Value Work: 0.188 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history

Literature

Characterization of a Novel Ser-Cisser-Lys Catalytic Triad in Comparison with the Classical Ser-His-Asp Triad.

Shin, S.Yun, Y.S.Koo, H.M.Kim, Y.S.Choi, K.Y.Oh, B.-H.

(2003) J.Biol.Chem. 278: 24937

  • DOI: 10.1074/jbc.M302156200
  • Primary Citation of Related Structures:  1O9N, 1O9O, 1O9P, 1O9Q, 1OBI, 1OBJ, 1OBK, 1OCH, 1OCK, 1OCL, 1OCM

  • PubMed Abstract: 
  • Amidase signature family enzymes, which are widespread in nature, contain a newly identified Ser-cisSer-Lys catalytic triad in which the peptide bond between Ser131 and the preceding residue Gly130 is in a cis configuration. In order to characterize ...

    Amidase signature family enzymes, which are widespread in nature, contain a newly identified Ser-cisSer-Lys catalytic triad in which the peptide bond between Ser131 and the preceding residue Gly130 is in a cis configuration. In order to characterize the property of the novel triad, we have determined the structures of five mutant malonamidase E2 enzymes that contain a Cys-cisSer-Lys, Ser-cisAla-Lys, or Ser-cisSer-Ala triad or a substitution of Gly130 with alanine. Cysteine cannot replace the role of Ser155 due to a hyper-reactivity of the residue, which results in the modification of the cysteine to cysteinyl sulfinic acid, most likely inside the expression host cells. The lysine residue plays a structural as well as a catalytic role, since the substitution of the residue with alanine disrupts the active site structure completely. The two observations are in sharp contrast with the consequences of the corresponding substitutions in the classical Ser-His-Asp triad. Structural data on the mutant containing the Ser-cisAla-Lys triad convincingly suggest that Ser131 plays an analogous catalytic role as the histidine of the Ser-His-Asp triad. The unusual cis configuration of Ser131 appears essential for the precise contacts of this residue with the other triad residues, as indicated by the near invariance of the preceding glycine residue (Gly130), structural data on the G130A mutant, and by a modeling experiment. The data provide a deep understanding of the role of each residue of the new triad at the atomic level and demonstrate that the new triad is a catalytic device distinctively different from the classical triad or its variants.


    Organizational Affiliation

    Center for Biomolecular Recognition, Pohang, Kyungbuk, 790-784, Korea.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
MALONAMIDASE E2
A, B
414Bradyrhizobium japonicumN/A
Find proteins for Q9ZIV5 (Bradyrhizobium japonicum)
Go to UniProtKB:  Q9ZIV5
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
MLA
Query on MLA

Download SDF File 
Download CCD File 
A, B
MALONIC ACID
DICARBOXYLIC ACID C3; PROPANEDIOLIC ACID; METHANEDICARBOXYLIC ACID
C3 H4 O4
OFOBLEOULBTSOW-UHFFFAOYSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2 Å
  • R-Value Free: 0.245 
  • R-Value Work: 0.188 
  • Space Group: P 21 21 2
Unit Cell:
Length (Å)Angle (°)
a = 103.629α = 90.00
b = 95.225β = 90.00
c = 74.981γ = 90.00
Software Package:
Software NamePurpose
PROSCALEdata scaling
CNSrefinement
SMARTdata reduction
CNSphasing

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

  • Deposited Date: 2003-01-31 
  • Released Date: 2004-02-13 
  • Deposition Author(s): Shin, S., Oh, B.-H.

Revision History 

  • Version 1.0: 2004-02-13
    Type: Initial release
  • Version 1.1: 2015-04-22
    Type: Data collection, Derived calculations, Non-polymer description, Other, Refinement description, Structure summary, Version format compliance